Comparative effect of dipeptidyl-peptidase 4 inhibitors on laboratory parameters in patients with diabetes mellitus

Abstract Background The purpose of this study was to evaluate and compare the effects on laboratory parameters among monotherapy with five DPP-4 inhibitors in patients with type 2 diabetes mellitus (DM). Methods We identified cohorts of new sitagliptin users (n = 879), vildagliptin users (n = 253),...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Yayoi Nishida, Yasuo Takahashi, Kotoe Tezuka, Hayato Akimoto, Tomohiro Nakayama, Satoshi Asai
Médium: Artigo
Jazyk:Inglês
Vydáno: BMC 2020-04-01
Edice:BMC Pharmacology and Toxicology
Témata:
Diabetes mellitus
Dipeptidyl-peptidase 4 inhibitor
Sitagliptin
Vildagliptin
Teneligliptin
Alogliptin
On-line přístup:http://link.springer.com/article/10.1186/s40360-020-00407-4
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky